EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Functions and Mechanisms of Diabetes-Linked Transcription Factors

Naveen K Parthiban, Najah T Nassif, Ann M Simpson

Frontiers in Bioscience-Landmark · 27.08.2025 · 30 (8)

DOI: 10.31083/fbl36544 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 27.08.2025. Verfasst von Naveen K Parthiban und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, University of Technology Sydney, Ultimo, NSW 2007, Australia. Hauptthemen laut MEDLINE: Transcription Factors, Diabetes Mellitus, Type 2, Diabetes Mellitus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transcription factors are significant regulators of gene expression in most biological processes related to diabetes, including beta cell (β-cell) development, insulin secretion and glucose metabolism. Dysregulation of transcription factor expression or abundance has been closely associated with the pathogenesis of type 1 and type 2 diabetes, including pancreatic and duodenal homeobox 1 (PDX1), neurogenic differentiation 1 (NEUROD1), and forkhead box protein O1 (FOXO1). Gene expression is regulated at the transcriptional level by transcription factor binding, epigenetically by DNA methylation and chromatin remodelling, and post-transcriptional mechanisms, including alternative splicing and microRNA (miRNA). Recent data indicate a central role for transcription factors in pancreatic β-cell failure in the context of systemic insulin resistance and chronic inflammation. Therapeutic modulation of transcription factor abundance via gene therapy, small-molecule pharmacology, and epigenetic therapies holds great promise for β-cell restoration and metabolic normalisation. However, further clinical translation will require targeted delivery to appropriate tissues, minimising off-target effects and ensuring long-term safety. This review focuses on the involvement of pancreatic β-cells and transcription factors in diabetes development and their therapeutic implications, intending to develop and consolidate a basis for further research in this area and for the treatment of diabetes in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription FactorsDiabetes Mellitus, Type 2Diabetes MellitusHumansInsulin-Secreting CellsAnimalsEpigenesis, GeneticGene Expression Regulation

Stichwörter der Autor:innen

chromatin remodelingdiabetesepigenetic therapyhepatic gluconeogenesisinflammatory responsesinsulin resistanceislet cell typeslipid metabolismmetabolic dysfunctionpancreatic transcription factors

Substanzen

Transcription Factors

Autor:innen und Institutionen

  • School of Life Sciences, University of Technology Sydney, Ultimo, NSW 2007, Australia.

Zitieren

APA

Parthiban, N. K., Nassif, N. T., & Simpson, A. M. (2025). Functions and Mechanisms of Diabetes-Linked Transcription Factors. Frontiers in Bioscience-Landmark, 30(8). https://doi.org/10.31083/fbl36544

Vancouver

Parthiban NK, Nassif NT, Simpson AM. Functions and Mechanisms of Diabetes-Linked Transcription Factors. Frontiers in Bioscience-Landmark. 2025;30(8). doi:10.31083/fbl36544

BibTeX
@article{Parthiban2025,
  author = {Parthiban, Naveen K and Nassif, Najah T and Simpson, Ann M},
  title = {Functions and Mechanisms of Diabetes-Linked Transcription Factors},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2025},
  volume = {30},
  number = {8},
  doi = {10.31083/fbl36544}
}
Kostenlos starten →